ENBIS-26 Conference

Session

Statistics in Pharma / Healthcare: Statistical Decision Support in Healthcare and Biomedical Development

Sep 7, 2026, 12:00 PM

Centro Didattico Morgagni

Conveners

Statistics in Pharma / Healthcare: Statistical Decision Support in Healthcare and Biomedical Development

• Marina Vives-Mestres

130. Towards an Adaptive Framework for Longitudinal Survival Modeling in Clinical Decision Support: Case of the ISPY 1 Trial

Abdelaziz Berrado (Mohammed V University, EMI)

9/7/26, 12:00 PM

Statistics in Pharma / Healthcare

Clinical surveillance of cancer patients is necessary to ensure early detection of recurrence aftercurative treatment and to monitor patient progression. Although clinical guidelines commonly recommend fixed surveillance schedules for all patients, static intervals between follow-up visits may not be compatible with individual disease progression, increasing the risk of delayed recurrence...

147. Predicting Study Success in Diagnostic Test Evaluation: A Case Study Using Frequentist and Bayesian Approaches

Alejandro Moreno Muñoz (Werfen)

9/7/26, 12:20 PM

Statistics in Pharma / Healthcare

In diagnostic test evaluation, agreement between a candidate method and a reference method is sometimes assessed using a composite comparator method when no gold standard is available. A composite comparator combines the results of multiple assays to derive a final adjudicated classification of the patients.

This work addresses the prediction of study success after a partial testing of an...